Wexham Park Hospital is a large NHS hospital in Slough, Berkshire. It has been managed by Frimley Health NHS Foundation Trust since 2014. Sir Andrew Morris is the chief executive of Frimley Health NHS Foundation Trust.

During the past decade, Wexham Park Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wexham Park Hospital" #1 sponsor was "University College, London" with 3 trials, followed by "University Hospital Southampton NHS Foundation Trust" with 3 trials sponsored, "Medical Research Council" with 2 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wexham Park Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Wexham Park Hospital" are "Fallopian Tube Cancer" (7 trials), "Ovarian Cancer" (7 trials), "Primary Peritoneal Cavity Cancer" (5 trials), "Lung Cancer" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Wexham Park Hospital" in a lesser frequency.

Most popular intervention types in "Wexham Park Hospital" are "Drug" (22 trials), "Procedure" (9 trials), "Biological" (7 trials), "Other" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (4 trials), "quality-of-life assessment" (4 trials), "adjuvant therapy" (3 trials), "capecitabine" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Wexham Park Hospital" are 19 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wexham Park Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Wexham Park Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wexham Park Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".